Market News How it works Learn FAQ
| RCT 0.0796 4.60% | NU 12.69 -16.29% | EWZ 34.43 -19.16% | BBD 2.935 -27.89% | TGL 0.2399 8.31% | AZTR 1.6199 126.56% | ITUB 7.75 -19.86% | NVD 3.9801 -5.01% | XP 15.9 -47.71% | SRTM 0.2985 -30.63% | WFF 0.0918 14.75% | SHFS 0.0943 -28.78% | SPCX 148.07 0.39% | PBR 22.515 -13.93% | SOXL 92.02 10.12% | VALE 11.96 -3.55% | CLRO 5.015 54.31% | INTC 91.38 5.08% | TSLL 10.875 11.42% | NVDA 216.37 2.56% | GCDT 0.1444 -18.00% | NOK 8.735 7.31% | NWGL 0.089 8.54% | BITO 10.66 -1.57% | SOXS 47.14 -10.14% | CRWV 56.4528 4.09% | RWM 14.485 -0.45% | JBLU 2.345 -10.67% | GPUS 0.1808 7.05% | ABEV 2.835 -14.09% | TSLG 5.44 11.70% | SGRY 23.245 47.59% | AAL 12.2501 1.16% | IREN 25.945 4.18% | INTR 4.6799 -34.91% | SBS 4.69 -26.72% | QID 14.175 -2.58% | TQQQ 68.805 3.79% | RBNE 0.17 -10.53% | T 20.9 -0.14% | SPDN 8.485 -0.64% | TSLA 393.715 5.77% | RIG 6.455 0.70% | WULF 12.225 7.99% | NFLX 63.745 -3.20% | SID 0.9078 -23.07% | LUCD 0.52 26.52% | GRAB 2.692 -3.51% | XTND 2.235 26.27% | PLUG 1.39 0.72%
SACassava Sciences, Inc. Warrant logo

Cassava Sciences, Inc. Warrant (SAVAW)

NASDAQ Global Market · Currency in USD
$0.03 ▲ +0.00 (+0.00%)
At close: Aug 19, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.03
Open
$0.10
Day's Range
$0.03 – $0.10
52 Week Range
$0.02 – $11.02
Volume
2,510,746
Avg. Volume
331,000
Market Cap
$1.45M
Beta (5Y Monthly)
-0.74
PE Ratio (TTM)
--
EPS (TTM)
--
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Cassava Sciences, Inc. Warrant

Sector
Healthcare
Industry
Biotechnology
Full-time employees
30
CEO
Richard Jon Barry

Cassava Sciences, Inc. is a biotechnology firm currently in the clinical development stage, dedicated to discovering therapies for neurodegenerative disorders. Their key therapeutic asset is simufilam, a small molecule drug that has already completed its Phase 2b clinical evaluation. Furthermore, the company is advancing SavaDx, a diagnostic tool utilizing blood-based biomarkers for the early detection of Alzheimer's disease.

Earnings

No earnings history available.

Get free alerts on SAVAW and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.